Physician profile
Deepthi Ganta
NPI 1982165643
$1,602.32
in general payments reported to CMS, 2019-2025
8 companies · $666 in 2025
The $666 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.47 · 2023: $163 · 2024: $754 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Education: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.44 |
| Education | $359.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $567.07 | 2024-2025 | Sprint Pns System |
| Medtronic, INC. | $307.31 | 2024-2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $261.84 | 2023-2025 | General - Pain Management |
| Medical Device Business Services, INC. | $190.56 | 2024 | Stratafix |
| Spinal Simplicity, LLC | $121.02 | 2024 | Ha Minuteman G3-R |
| Mml US, INC. | $118.39 | 2024 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 | |
| Nevro Corp. | $17.66 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepthi Ganta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.